Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. 2002 S9 (2002) Center for drug evaluation and research. Application number 21–436. Medical review(s). https://www.fdagov
2. Belgamwar RB, El-Sayeh HG (2011) Aripiprazole versus placebo for schizophrenia. Cochrane Database Syst Rev: CD006622
3. Brooks S, Gelman A (1998) General methods for monitoring convergence of iterative simulations. J Comput Graph Stat 7:434–455
4. Cantillon M, Prakash A, Alexander A, Ings R, Sweitzer D, Bhat L (2017) Dopamine serotonin stabilizer RP5063: a randomized, double-blind, placebo-controlled multicenter trial of safety and efficacy in exacerbation of schizophrenia or schizoaffective disorder. Schizophr Res 189:126–133
5. Citrome L, Ota A, Nagamizu K, Perry P, Weiller E, Baker RA (2016) The effect of brexpiprazole (OPC-34712) and aripiprazole in adult patients with acute schizophrenia: results from a randomized, exploratory study. Int Clin Psychopharmacol 31:192–201
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献